Transferrin dependence of Ga (NO3)3 inhibition of growth in human- derived small cell lung cancer cells

Journal of Cellular Biochemistry

Volumn 62, Issue SUPPL. 24, 1996, Pages 276-287

  Weiner, Ronald E ^a,d   Avis, Ingallil ^c   Neumann, Ronald D ^b   Mulshine, James L ^c  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Ga nitrate; small cell lung cancer; transferrin; transferrin receptors

Indexed keywords

GALLIUM NITRATE; MONOCLONAL ANTIBODY; TRANSFERRIN RECEPTOR; GALLIUM; GROWTH INHIBITOR; TRANSFERRIN; TUMOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG EFFECT; DRUG SCREENING; DRUG UPTAKE; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; CELL CULTURE; CELL DIVISION; CULTURE MEDIUM; DRUG ANTAGONISM; IMMUNOLOGY; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; SMALL CELL CARCINOMA;

ANTIBODIES, MONOCLONAL; CARCINOMA, SMALL CELL; CELL DIVISION; CULTURE MEDIA; GALLIUM; GROWTH INHIBITORS; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; RECEPTORS, TRANSFERRIN; TRANSFERRIN; TUMOR CELLS, CULTURED;

EID: 0029798234     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.240630523     Document Type: Article

References (35)

1. Cazzola M, Bergamaschi G, Dezza L, Arosio P (1990): Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: Achievements and prospects. Blood 75:1903-1919.
2. Reichard P, Eherenberg A (1983): Ribonucleotide reductase: A radical enzyme. Science 221:514-519.
3. Crichton RR, Ward RJ (1992): Iron metabolism: New perspectives in view. Biochemistry 31:11255-11264.
4. Taetle R (1990): The role of transferrin receptors in hemopoietic cells growth. Exp Hematol 18:360-365.
5. Oie HK, Russell EK, Desmond NC, Gazdar AF (1996): Cell culture methods for the establishment of the NCI series of lung cancer cell lines. J Cell Biochem (in press).
6. Mulshine JL, Treston AM, Scott FM, Avis I, Boland C, Phelps R, Kasprzyk PG, Nakanishi Y, Cuttitta F (1991): Lung cancer: Rational strategies for early detection and intervention. Oncology 5:25-32.
7. Hoffer PB (1980): Gallium: Mechanisms. J Nucl Med 21:282-284.
8. 67Ga localization. Nucl Med Biol 17:141-149.
9. Chitambar CR, Zivkovic Z (1987): Uptake of gallium-67 by human leukemic cells: Demonstration of transferrin receptor-dependent and transferrin-independent mechanisms. Cancer Res 47:3929-3934.
10. Chitambar CR, Matthaeus WG, Antholine WE, Graff K, O'Brien WJ (1988): Inhibition of leukemic HL60 cell growth by transferrin-gallium: Effects on ribonucleotide reductase and demonstration of drug synergy with hydroxyurea. Blood 72:1930-1936.
11. Hedley DW, Tripp EH, Slowiaczek P, Mann GJ (1988): Effect of gallium on DNA synthesis by human T-cell lymphoblasts. Cancer Res 48:3014-3018.
12. Chitambar CR, Narasimhan J, Guy J, Sem DS, O'Brien WJ (1991): Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells. Cancer Res 51:6199-6201.
13. Feremans W, Bujan W, Neve P, Delville JP, Schandene L (1991): CD71 phenotype and the value of gallium imaging in lymphomas. Am J Hematol 36:215-216.
14. Tsuchiya Y, Nakao A, Komatsu T, Yamamoto M, Shimokata K (1992): Relationship between gallium 67 citrate scanning and transferrin receptor expression in lung diseases. Chest 102:530-534.
15. Foster B, Clagett-Carr K, Hoth D, Leyland-Jones B (1986): Gallium nitrate: The second metal with clinical activity. Cancer Treat Rep 70:1311-1319.
16. Warrell RP Jr, Coonley CJ, Straus DJ, Young CW (1983): Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a sevenday continuous infusion. Cancer 51:1982-1987.
17. Gupta AD, Shah VI (1990): Correlation of transferrin receptor expression with histologie grade and immunophenotype in chronic lymphocytic leukemia and non-Hodgkin's lymphoma. Hematol Pathol 4:37-41.
18. Kaplan J, Jordan I, Sturrock A (1991): Regulation of the transferrin-independent iron transport system in cultured cells. J Biol Chem 266:2997-3004.
19. Chitambar CR, Sax D (1992): Regulatory effects of gallium on transferrin-independent iron uptake by human leukemic HL60 cells. Blood 80:505-511.
20. Seligman PA, Moran PL, Schleicher RB, Crawford ED (1992): Treatment with gallium nitrate: Evidence for interference with iron metabolism in vivo. Am J Hematol 41:232-240.
21. Sohn M-E, Jones BJ, Whiting JH, Datz FL, Lynch RE, Morton KA (1993): Distribution of gallium-67 in normal and hypotransferrinemic tumor-bearing mice. J Nucl Med 34:2135-2143.
22. White S, Taetle R, Seligman PA, Rutherford M, Trowbridge IS (1990): Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: Evidence for synergistic antiproliferative effects. Cancer Res 50:6295-6301.
23. Kemp JD, Smith KM, Kanner LJ, Gomez F, Thorson JA, Naumann PW (1990): Synergistic inhibition of lymphoid tumor growth in vitro by combined treatment with the iron chelator deferoxamine and an immunoglobulin G monoclonal antibody against the transferrin receptor. Blood 76:991-995.
24. Taetle R, Honeysett JM, Bergeron R (1989): Combination iron depletion therapy. J Natl Cancer Inst 81:1229-1235.
25. Nakanishi Y, Cuttitta F, Kasprzyk PG, Avis I, Steinberg MS, Gazdar AF, Mulshine JL (1988): Growth factors effects on small cell lung cancer cells using a colorimetric assay: Can a transferrin-like factor mediate autocrine growth. Exp Cell Biol 56:74-85.
26. Vostrejs M, Moran PL, Seligman PA (1988): Transferrin synthesis by small cell lung cancer cells acts as an autocrine regulator of cellular proliferation. J Clin Invest 82:331-339.
27. Trowbridge IS, Lopez F (1982): Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro. Proc Natl Acad Sci USA 79:1175-1180.
28. Gazdar AF, Carney DN, Nau MN, Minna JD (1985): Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive, biochemical, morphological, and growth properties. Cancer Res 45:2924-2930.
29. Feldman HA (1983): Statistics. In Rothfield B (ed): "Nuclear Medicine In Vitro," 2nd ed. Philadelphia: J.B. Lippincott Co., pp 10-34.
30. 67Ga Localization in Malignant Disease. Nucl Med Biol (in press).
31. Green MA, Welch MJ (1989): Gallium radiopharmaceutical chemistry. Nucl Med Biol 16:435-448.
32. Shterman N, Kupfer B, Moroz C (1991): Comparison of transferrin receptors, iron content and isoferritin profile in normal and malignant human breast cell lines. Pathobiology 59:19-25.
33. Sorokin LM, Morgan EH, Yeoh CT (1989): Transformation-induced changes in transferrin and iron metabolism in myogenic cells. Cancer Res 49:1941-1947.
34. Collawn JF, Lai A, Domingo D, Fitch M, Hatton S, Trowbridge IS (1993): YTRF is the conserved internalization signal of the transferrin receptor, and a second YTRF signal at position 31-34 enhances endocytosis. J Biol Chem 268:21686-21692.
35. 3 uptake by human-derived small cell lung cancer cells. Seventh International Symposium on Radiopharmacology, Boston, MA, June 1991.